These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 31602361)

  • 1. Graves' Disease Induced by Immune Checkpoint Inhibitors: A Case Report and Review of the Literature.
    Brancatella A; Viola N; Brogioni S; Montanelli L; Sardella C; Vitti P; Marcocci C; Lupi I; Latrofa F
    Eur Thyroid J; 2019 Jul; 8(4):192-195. PubMed ID: 31602361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.
    Yamada H; Okajima F; Onda T; Fujimori S; Emoto N; Sugihara H
    BMC Endocr Disord; 2020 Aug; 20(1):132. PubMed ID: 32847555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graves' Disease during Immune Checkpoint Inhibitor Therapy (A Case Series and Literature Review).
    Peiffert M; Cugnet-Anceau C; Dalle S; Chikh K; Assaad S; Disse E; Raverot G; Borson-Chazot F; Abeillon-du Payrat J
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33920721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab-Induced Hypothyroidism in a Patient With Pre-existing Triiodothyronine (T3) Thyrotoxicosis Due to Graves' Disease: A Case Report and Literature Review.
    Oyibo SO; Mahgoub MO
    Cureus; 2021 Nov; 13(11):e19736. PubMed ID: 34812334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Rare Case of Pembrolizumab-Associated Graves' Disease.
    Alqaisi S; Rahman A
    Cureus; 2023 Feb; 15(2):e34696. PubMed ID: 36909047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune checkpoint inhibitor-related thyroid dysfunction.
    Iwama S; Kobayashi T; Yasuda Y; Arima H
    Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101660. PubMed ID: 35501263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves' disease: case report.
    Elsherbiny TM
    Ther Adv Endocrinol Metab; 2024; 15():20420188241256470. PubMed ID: 38808008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune Thyroid Diseases.
    Petranović Ovčariček P; Görges R; Giovanella L
    Semin Nucl Med; 2024 Mar; 54(2):219-236. PubMed ID: 38044176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Hashimoto's thyroiditis following Graves' disease.
    Oueslati I; Salhi S; Yazidi M; Chaker F; Chihaoui M
    Clin Case Rep; 2022 Oct; 10(10):e6466. PubMed ID: 36254153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report.
    Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K
    J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Graves' disease with only unilateral involvement; a case report.
    Bu Bshait MS
    Int J Surg Case Rep; 2024 Jan; 114():109138. PubMed ID: 38086135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hashimoto's thyroiditis following Graves' disease.
    Umar H; Muallima N; Adam JM; Sanusi H
    Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothyroidism After Use of Immune Checkpoint Inhibitor Therapy in Patient With Graves' Disease: Cure?
    Sharma R
    JCEM Case Rep; 2023 Jan; 1(1):luac024. PubMed ID: 37908246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.
    Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A
    J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of TSH-receptor antibody with the clinical and laboratory parameters in patients with newly diagnosed Graves' hyperthyroidism: experience from a tertiary referral center including a large number of patients with TSH-receptor antibody-negative patients with Graves' hyperthyroidism.
    Zuhur SS; Bilen O; Aggul H; Topcu B; Celikkol A; Elbuken G
    Endokrynol Pol; 2021; 72(1):14-21. PubMed ID: 32944926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of positive antithyroid antibodies is observed in patients with thyroid dysfunction related to immune check point inhibitors.
    Mazarico I; Capel I; Giménez-Palop O; Albert L; Berges I; Luchtenberg F; García Y; Fernández-Morales LA; De Pedro VJ; Caixàs A; Rigla M
    J Endocrinol Invest; 2019 Dec; 42(12):1443-1450. PubMed ID: 31093955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Graves' disease coexisted with resistance to thyroid hormone: a case report.
    Akahori H; Usuda R
    J Med Case Rep; 2021 Sep; 15(1):473. PubMed ID: 34560890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.